Comparison of local corticosteroid injection and high-intensity laser outcomes in moderate carpal tunnel syndrome (CTS)

Not Applicable

Recruiting

Conditions: Carpal tunnel syndrome.
Carpal tunnel syndrome
G56.0

Registration Number: IRCT20200219046552N1

Lead Sponsor: Rasht University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 126

Inclusion Criteria

Patients with unilateral or bilateral CTS according to Median Nerve Electrophysiology (EMG-NCV) studies will be enrolled.

Exclusion Criteria

History of wrist surgery, polyneuropathy, brachial plexopathy or thoracic outlet syndrome
History of thrombocytopenia, platelet disorder, systemic infection, pregnancy and rheumatologic disorders.
Previous injection of cortisone for treatment of CTS
Thenar muscle atrophy

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptom severity scale in Boston Carpal Tunnel Syndrome Questionnaire. Timepoint: Measurement of symptom severity at baseline and 6 months later. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.;Functional status scale in Boston Carpal Tunnel Syndrome Questionnaire. Timepoint: Measurement of functional status at baseline and 6 months later. Method of measurement: Boston Carpal Tunnel Syndrome Questionnaire.

Secondary Outcome Measures

Name	Time	Method
Severity of pain. Timepoint: At baseline and 6 months after intervention. Method of measurement: Visual analog scale.;Distal sensory latency. Timepoint: At baseline and 6 months after intervention. Method of measurement: Based on the amount recorded by the EMG-NCV device.;Distal motor latency. Timepoint: At baseline and 6 months after intervention. Method of measurement: Based on the amount recorded by the EMG-NCV device.;Medical complications. Timepoint: 6 months after intervention. Method of measurement: Based on individual response.